Big Gain For Aileron Therapeutics, Inc.
Thu 28 May 20 at 05:30 PM
Aileron Therapeutics, Inc. (ALRN:NASDAQ) shot up at $1.32, representing a gain of 36.4%. On Wed 27 May 20, ALRN:NASDAQ touched a New 2-Week High of $0.97. The stock got featured on our News Catalysts scanner on Wed 27 May 20 at 10:41 AM in the 'INVESTOR UPDATE' category. From Wed 13 May 20, the stock recorded 66.67% Up Days and 40.00% Green Days
About Aileron Therapeutics, Inc. (ALRN:NASDAQ)
Aileron Therapeutics Inc is a clinical-stage biopharmaceutical company that is focused on developing and commercializing a novel class of therapeutics called stapled peptides.
Top 10 Gainers:
- ARCA biopharma, Inc. (ABIO:NASDAQ), 386.33%
- Hexindai Inc. (HX:NASDAQ), 170.83%
- HUSN (HUSN:NASDAQ), 72.29%
- Aileron Therapeutics, Inc. (ALRN:NASDAQ), 36.43%
- International Tower Hill Mines Ltd. (THM:NYSEMKT), 36.35%
- PhaseBio Pharmaceuticals, Inc. (PHAS:NASDAQ), 36.2%
- Live Ventures Incorporated (LIVE:NASDAQ), 35.31%
- Miragen Therapeutics (MGEN:NASDAQ), 35.29%
- Organogenesis Holdings Inc. (ORGO:NASDAQ), 33.24%
- Town Sports International Holdings, Inc. (CLUB:NASDAQ), 31.58%